Moneycontrol
HomeNewsBusinessCNBC-TV18 CommentsSun's merger plans: Taro's shareholders may play spoilsport
Trending Topics

Sun's merger plans: Taro's shareholders may play spoilsport

The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro’s large shareholders may play spoilsport, reports CNBC-TV18's Archana Shukla.

October 20, 2011 / 08:34 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro

first published: Oct 19, 2011 10:11 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!